1-20 of 873 Search Results for

approval

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
×Close Modal
Sort by
Journal Article
Journal of Health Politics, Policy and Law (1 June 2004) 29 (3): 431–442.
Published: 01 June 2004
...Daniel Carpenter © 2004 by Duke University Press 2004 Carpenter, Daniel P. 2000 . Protection without Capture: Drug Approval by a Politically Responsive, Bayesian Regulator . Robert Wood Johnson Foundation Scholars in Health Policy Working Paper No. 13. ———. 2002 . Groups, the Media...
Image
Published: 01 April 2014
Figure 3 Approval of the ACA by Age Source : Kaiser Health Tracking Poll, April 9–14, 2010 Figure 3. Approval of the ACA by Age. / Source: Kaiser Health Tracking Poll, April 9–14, 2010 More
Journal Article
Journal of Health Politics, Policy and Law (1 April 2019) 44 (2): 315–331.
Published: 01 April 2019
...Brad Wright; Anna Porter; Phillip M. Singer; David K. Jones Abstract Section 1332 of the Affordable Care Act (ACA) establishes state innovation waivers, which if approved allow states to waive certain ACA requirements, provided that insurance coverage remains comparable to the ACA with respect to...
Image
Published: 01 December 2013
Figure 2 Coverage Restrictions for Eligible Anticancer Drugs, FDA Approved, 2004–2008 Source : Mason et al. 2010 . Reprinted with permission. © 2010 American Society of Clinical Oncology. All rights reserved. Figure 2. Coverage Restrictions for Eligible Anticancer Drugs, FDA Approved, 2004 More
Image
Published: 01 April 2016
Figure 1 Trends in NDA Approvals for Publicly Traded Firms, 1999–2009 Source : Authors' analyses of data from Drugs@FDA for publicly traded firms. Complete description in “Data” section. Notes : NDAs=new drug applications; NME=new molecular entity Figure 1. Trends in NDA Approvals for More
Journal Article
Journal of Health Politics, Policy and Law (1 August 2003) 28 (4): 615–658.
Published: 01 August 2003
...Mary E. Wiktorowicz Although industrialized nations regulate pharmaceuticals to ensure their safety and efficacy, they balance these concerns with those related to the timeliness of the approval process and the burdens involved in meeting regulatory criteria. The United States, Canada, Britain, and...
Journal Article
Journal of Health Politics, Policy and Law (1 February 1981) 6 (1): 40–48.
Published: 01 February 1981
... are discussed in light of positions taken by regulators, providers and consumers. By highlighting the trade-offs involved, the authors point out the limitations of regulation in this emotion-laden area. Former Secretary Patricia Roberts Harris approved a final version of human rights provisions on her...
Journal Article
Journal of Health Politics, Policy and Law (1 December 2017) 42 (6): 1039–1064.
Published: 01 December 2017
...Marian Jarlenski; Philip Rocco; Renuka Tipirneni; Amy Jo Kennedy; Nivedita Gunturi; Julie Donohue Abstract Since the Supreme Court decided that the Affordable Care Act's (ACA) Medicaid expansion is optional for the states, several have obtained federal approval to use Section 1115 waivers to expand...
Journal Article
Journal of Health Politics, Policy and Law (1 August 2011) 36 (4): 691–716.
Published: 01 August 2011
... supply of organs for transplantation from the deceased. Ethical issues were raised in government committees appointed to discuss the policy before its approval, but discussions among laypeople were not solicited. This study aimed to elicit laypeople's views about the policy by conducting thirteen group...
Journal Article
Journal of Health Politics, Policy and Law (1 June 2013) 38 (3): 545–571.
Published: 01 June 2013
... efficacy information that the provinces use comes from the federal government. We interviewed drug plan officials from eight of the ten provinces and two of three territories regarding their views on the Canadian drug safety system. Here we report on the following categories: the federal drug approval...
Journal Article
Journal of Health Politics, Policy and Law (1 June 1978) 3 (3): 375–387.
Published: 01 June 1978
... objectives of Titles XIX and IV-A, respectively, of the Social Security Act. In the Georgia case, however, the plaintiffs contended that federal regulations protecting human subjects were applicable to the experiment at issue. While the precedent of past cases upholding the Secretary's authority to approve...
Journal Article
Journal of Health Politics, Policy and Law (1 February 1991) 16 (1): 121–134.
Published: 01 February 1991
.... We distinguish differences in attitude and demographic characteristics in three groups: those committed to donation, those opposed, and those who might change their opinions with more specific information. While approval of donation is nearly universal, only about half of the public would donate a...
Journal Article
Journal of Health Politics, Policy and Law (1 February 2014) 39 (1): 239–246.
Published: 01 February 2014
... Americans. This act provides multiple routes for determining which preventive services receive this designation. Three of these routes should be considered as pathways for reimbursing WGS, including approval by the United States Preventive Services Task Force, inclusion in the guidelines of the American...
Journal Article
Journal of Health Politics, Policy and Law (1 October 2015) 40 (5): 1001–1021.
Published: 01 October 2015
...Federico Toth Abstract This article focuses on the main health reforms enacted in Italy over the past one hundred years. Such reforms were all undertaken in conjunction with a severe political and institutional crisis. The 1943 reform was approved a few weeks before the fall of the Fascist regime...
Journal Article
Journal of Health Politics, Policy and Law (1 April 2016) 41 (2): 157–179.
Published: 01 April 2016
...Figure 1 Trends in NDA Approvals for Publicly Traded Firms, 1999–2009 Source : Authors' analyses of data from Drugs@FDA for publicly traded firms. Complete description in “Data” section. Notes : NDAs=new drug applications; NME=new molecular entity Figure 1. Trends in NDA Approvals for...
Journal Article
Journal of Health Politics, Policy and Law (1 August 1982) 6 (4): 718–738.
Published: 01 August 1982
... annual dollar limit would be placed on the capital expenditures that could be approved for future Medicare-Medicaid reimbursement. This limitation would create a set of incentives leading to close community scrutiny of capital expenditures, and would allow changes in the institutional structure of...
Journal Article
Journal of Health Politics, Policy and Law (1 February 1984) 9 (1): 103–124.
Published: 01 February 1984
... the planning process on HMOs, and the possibility that negative perceptions of regulation may have led HMOs to refrain from activities requiring planning approval. Both studies reveal that health planning review was detrimental to 20 to 30 percent of HMOs. Thus data collected during the period of...
Journal Article
Journal of Health Politics, Policy and Law (1 June 1984) 9 (3): 453–473.
Published: 01 June 1984
...Eugenia S. Carpenter; Pamela Paul-Shaheen This paper traces the implementation of Michigan's program for hospital bed reduction through four phases in the critical first 30 months following enactment: standard-setting, plan development, plan approval, and legislative oversight. Procedural...
Journal Article
Journal of Health Politics, Policy and Law (1 June 1988) 13 (3): 565–579.
Published: 01 June 1988
... be satisfactorily answered before approval is given. The paper concludes that if done properly, home transfusions can be safe, cost-effective, and convenient for a carefully selected segment of patients. Copyright © 1988 by Duke University Press 1988 References American Association of Blood...
Journal Article
Journal of Health Politics, Policy and Law (1 December 2009) 34 (6): 979–1010.
Published: 01 December 2009
... both health care administrators and patients for high-quality, low-cost medicines and the objective of the innovator pharmaceutical industry to find and approve new drugs that are price protected and sell them in a way that maximizes revenues. Duke University Press 2009 Abbott, F. M. 2004...